FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely psychiatry and may be used for treating depression. For this purpose, a therapeutically effective amount of a combination of telenzepine and one or more antidepressants specified in a group consisting of fluoxetine, sertraline and venlafaxine are introduced in an individual in need thereof. There are also presented a pharmaceutical composition and a kit for treating depression.
EFFECT: group of inventions provides treating depression in an individual, as well as more intensive antidepressant action, than that ensured by introducing any of said drugs separately.
15 cl, 6 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
TREATMENT OF OBESITY WITH ANTAGONISTS OF MUSCARINIC RECEPTOR M1 | 2007 |
|
RU2455981C2 |
CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR PHRENOPATHY TREATMENT | 2003 |
|
RU2356554C2 |
CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR TREATING PHRENOPATHIES | 2008 |
|
RU2389490C2 |
THE SELECTIVE INVERSE AGONISTS OF SEROTONIN RECEPTORS AS MEDICATION TO CURE DISEASES | 2005 |
|
RU2442607C2 |
PREVENTIVE OR THERAPEUTIC AGENT FOR DEPRESSION OR ANXIETY DISORDER | 2006 |
|
RU2413510C2 |
COMBINED MEDICATION FOR WEIGHT-REDUCING TREATMENT | 2004 |
|
RU2363458C2 |
LAYERED PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2452471C2 |
ORGANIC COMPOUNDS | 2015 |
|
RU2785871C2 |
ORGANIC COMPOUNDS | 2015 |
|
RU2728787C2 |
COMBINATION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENTS SUFFERING WITH DEPRESSION | 1997 |
|
RU2181287C2 |
Authors
Dates
2013-03-20—Published
2007-06-15—Filed